Matches in Wikidata for { <http://www.wikidata.org/entity/Q71975324> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q71975324 description "article scientifique publié en 1997" @default.
- Q71975324 description "articolo scientifico (pubblicato il 1997)" @default.
- Q71975324 description "artikull shkencor i botuar më 01 janar 1997" @default.
- Q71975324 description "artículu científicu espublizáu en xineru de 1997" @default.
- Q71975324 description "im Januar 1997 veröffentlichter wissenschaftlicher Artikel" @default.
- Q71975324 description "scientific article published on 01 January 1997" @default.
- Q71975324 description "wetenschappelijk artikel" @default.
- Q71975324 description "наукова стаття, опублікована в січні 1997" @default.
- Q71975324 name "Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer" @default.
- Q71975324 name "Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer" @default.
- Q71975324 name "Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer" @default.
- Q71975324 type Item @default.
- Q71975324 label "Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer" @default.
- Q71975324 label "Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer" @default.
- Q71975324 label "Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer" @default.
- Q71975324 prefLabel "Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer" @default.
- Q71975324 prefLabel "Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer" @default.
- Q71975324 prefLabel "Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer" @default.
- Q71975324 P1433 Q71975324-7E1723D7-4C6D-4C06-BDAA-59304321D74E @default.
- Q71975324 P1476 Q71975324-A70879CE-8EB7-43F3-8C00-B3882B2972B7 @default.
- Q71975324 P2093 Q71975324-33AE44C1-3B4B-45B1-8D00-12091A25548F @default.
- Q71975324 P2093 Q71975324-36AF6C55-38BF-4778-8325-A7F38925A27C @default.
- Q71975324 P2093 Q71975324-51E92604-C9BB-4BD1-BF17-B7F5DFD4C1A0 @default.
- Q71975324 P2093 Q71975324-606D73B6-A324-4A4D-9190-273D7F02A90D @default.
- Q71975324 P2093 Q71975324-677179AE-F618-4780-9FB8-175A4C0F4F2A @default.
- Q71975324 P2093 Q71975324-6A1CF478-8A91-41B9-898B-1514A4A54982 @default.
- Q71975324 P2093 Q71975324-72347CBD-D03D-4886-9713-4132F5DF3877 @default.
- Q71975324 P2093 Q71975324-A0BFE670-2C40-42FB-8012-4395BF37011D @default.
- Q71975324 P2093 Q71975324-CB5A74C9-89C5-47E3-B199-335BBC8D29B3 @default.
- Q71975324 P2093 Q71975324-E9FBD2ED-B1FE-48BB-8960-BF433CDF2B51 @default.
- Q71975324 P2093 Q71975324-F5F470BA-F95F-4B04-BA8E-C08BFD8A4D61 @default.
- Q71975324 P304 Q71975324-D249DE69-6D07-435C-8EBB-B62E5DD18385 @default.
- Q71975324 P31 Q71975324-DD8AC377-D995-4F52-95E0-75E475CAE8F9 @default.
- Q71975324 P356 Q71975324-B32D4391-9402-4422-ACC1-55550B25B53A @default.
- Q71975324 P407 Q71975324-B41DA987-986E-464D-81C9-168E4AA906D8 @default.
- Q71975324 P433 Q71975324-C8DE7AA8-1AED-4207-B13D-6A5470B6074F @default.
- Q71975324 P478 Q71975324-FB1E5A9B-F62B-4339-A8DC-48487BAC3989 @default.
- Q71975324 P577 Q71975324-F2A93BBC-18E3-4708-97EF-D198D16D5F79 @default.
- Q71975324 P698 Q71975324-FB48CEAF-2B5A-411C-9101-684F8A7BB8CC @default.
- Q71975324 P921 Q71975324-0B16F998-2F6E-48F6-B728-6E1C4A2CE10F @default.
- Q71975324 P356 JCO.1997.15.1.148 @default.
- Q71975324 P698 8996136 @default.
- Q71975324 P1433 Q400292 @default.
- Q71975324 P1476 "Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer" @default.
- Q71975324 P2093 "B A Burtness" @default.
- Q71975324 P2093 "D Beidler" @default.
- Q71975324 P2093 "D Belliveau" @default.
- Q71975324 P2093 "D Zelterman" @default.
- Q71975324 P2093 "G Pizzorno" @default.
- Q71975324 P2093 "I Tocino" @default.
- Q71975324 P2093 "J Fedele" @default.
- Q71975324 P2093 "J R Murren" @default.
- Q71975324 P2093 "S Anderson" @default.
- Q71975324 P2093 "S D Flynn" @default.
- Q71975324 P2093 "Y C Cheng" @default.
- Q71975324 P304 "148-157" @default.
- Q71975324 P31 Q13442814 @default.
- Q71975324 P356 "10.1200/JCO.1997.15.1.148" @default.
- Q71975324 P407 Q1860 @default.
- Q71975324 P433 "1" @default.
- Q71975324 P478 "15" @default.
- Q71975324 P577 "1997-01-01T00:00:00Z" @default.
- Q71975324 P698 "8996136" @default.
- Q71975324 P921 Q725307 @default.